It exhibits a nonspecific immune response to reduce tumor burden by increasing the number of natural killer (NK) cells and CD8+ T cells and by cytokine secretion, including that of interleukin (IL)-2, IL-12, IL-18, and interferon-gamma (INF-γ) (5, 6). The gene discussed is IL2; the disease is neoplasm.